Dogwood Therapeutics DWTX Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$4.99M-31.9% | -$3.78M+76.0% | -$15.74M-314% | -$3.81M+65.1% | -$10.92M-41.4% | ||
| —— | —— | —— | $17.26K+1.4% | $17.02K+459% | ||
| $449.42K+185% | $157.86K+227% | $48.28K-25.8% | $65.03K-23.0% | $84.47K-9.9% | ||
| -$4.59M-26.1% | -$3.64M-11.1% | -$3.27M+18.7% | -$4.03M+14.0% | -$4.68M+23.6% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $11.29M+34,577% | $32.56K— | —— | —— | $7.37M-51.9% | ||
| $6.7M+286% | -$3.6M-10.1% | -$3.27M+21.1% | -$4.15M-254% | $2.69M-79.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Dogwood Therapeutics generate?
- Dogwood Therapeutics (DWTX) generated -$15.5M in operating cash flow over the trailing twelve months.
- Where does Dogwood Therapeutics's cash flow data come from?
- Every line is extracted from Dogwood Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.